https://mycn.org.uk/
Home - MYCN
mycn
https://scholars.duke.edu/publication/1405534
Scholars@Duke publication: MYCN amplification drives an aggressive form of spinal ependymoma.
https://sj.jst.go.jp/news/202604/n0415-03k.html
MYCN gene expression as an indicator for predicting the risk of liver cancer development | News |...
MYCN gene expression as an indicator for predicting the risk of liver cancer development
https://profiles.uchicago.edu/profiles/display/247629
Locoregional MYCN-amplified neuroblastoma. | Profiles RNS
mycnamplifiedneuroblastomaprofilesrns
https://profiles.uchicago.edu/profiles/display/32278012
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma...
https://eprints.ncl.ac.uk/208621
Characteristics of UK patients with relapsed, intermediate risk unresectable, non-MYCN amplified...
https://severus.dbmi.pitt.edu/wiki-MPM/index.php/pair/view/55294/4613
FBXW7 and MYCN - Wiki-MPM
Wiki-wiki: a wiki resource centered on human protein-protein interactions
mycnwikimpm
https://research.ugent.be/web/result/project/577fcbc9-dc2a-4674-ae20-7741627525c3/details/en
Research Explorer - (3F004304) Quantitative proteome analysis of MYCN oncoprotein function and...
Research Explorer - Basic information about research project Quantitative proteome analysis of MYCN oncoprotein function and identification of molecular...
research explorerquantitativeproteome
https://pubmed.ncbi.nlm.nih.gov/40594589/?dopt=Abstract
Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma,...
BMI1, a constituent of polycomb repressive complex 1, is overexpressed in a variety of cancers, including neuroblastoma, highlighting its potential as a target...
inhibition
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.647737/full
Frontiers | The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
MYCN gene amplification and upregulated expression are major hallmarks in the progression of high-risk neuroblastoma. MYCN expression and function in modulat...
frontiersmicrornalandscapemycnamplified
https://pubmed.ncbi.nlm.nih.gov/41915328/
Integrating spatial and single-cell transcriptomics analysis reveals MYCN-UBE2C-TFRC signaling...
MYCN amplification is a recurrent, high-risk molecular hallmark across diverse tumors, most notably neuroectodermal malignancies. Although MYCN-driven tumors...
single cell transcriptomics
https://amsdottorato.unibo.it/id/eprint/690/
Inibizione selettiva del gene MYCN mediante PNA (acidi peptido nucleici) anti-gene nel...
https://pubmed.ncbi.nlm.nih.gov/32060267/
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
Aggressive cancers often have activating mutations in growth-controlling oncogenes and inactivating mutations in tumor-suppressor genes. In neuroblastoma,...
mycnamplificationatrxmutationsincompatible
https://www.mycn.or.tz/
MYCN
An uprising software company based in Tanzania. We transform visionary concepts into robust software solutions.
mycn
https://research.ugent.be/web/result/project/09c02375-790a-4968-8cac-35e4f72c8199/details/nl
Research Explorer - (365A1215) Geneesmiddelenresistentie bij MYC / MYCN aangedreven tumor...
Research Explorer - Basisinformatie over onderzoeksproject Geneesmiddelenresistentie bij MYC / MYCN aangedreven tumor entiteiten als gevolg van replicatieve...
research explorerbijmycaangedreventumor